| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atea Pharmaceuticals, Inc. (AVIR) has 7 insiders with recent SEC Form 4 filings, including 5 buys and 3 sells. AVIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 506.5K | $2.81M | - | |
| Dir | 164.8K | $913.0K | - | |
| Dir | 112.8K | $624.6K | - | |
| Dir | 95.2K | $527.4K | - | |
| Dir | 86.0K | $476.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Hammond Janet Mj | Chief Development Officer | Sale+OE | 14,029 | $3.84 | $53,913.45 | -28.4% | -8.8% | -27.5% | |
| Nov 14, 2022 | Berger Franklin M52 | Director | Sell | 41,666 | $5.15 | $214,684.55 | -2.6% | -17.5% | -41.2% | |
| Dec 20, 2021 | Murphy Polly A. | Director | Buy | 12,000 | $8.57 | $102,795.60 | +106.2% | -18.9% | -47.0% | |
| Nov 3, 2020 | Rock Springs Capital Management LP | 10% Owner | Buy | 250,000 | $24.00 | $6,000,000.00 | +14.8% | - | - | |
| Nov 3, 2020 | Hack Andrew A. F.62 | Director | Buy | 250,000 | $24.00 | $6,000,000.00 | +4.7% | - | - | |
| Nov 3, 2020 | Berger Franklin M52 | Director | Buy | 41,666 | $24.00 | $999,984.00 | +5.4% | - | - |